DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Zhou F.
Pirfenidone capsules [three 267-mg capsules TID] for treatment of patients with idiopathic pulmonary fibrosis to reduce decline in lung function (Statistical Briefing Document).
In: Seymour S, ed.
FDA Briefing Information for the March 9, 2010 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC). NDA 22-535.
Washington, D.C.: US Food and Drug Administration; 2010: 110-158 Available from:
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM203081.pdf [accessed 2010 May 10]
We do not assume any responsibility for the contents of the web pages of other providers.